...
首页> 外文期刊>Frontiers in Neuropharmacology >The Effect of Transcranial Direct Current Stimulation on Relapse, Anxiety, and Depression in Patients With Opioid Dependence Under Methadone Maintenance Treatment: A Pilot Study
【24h】

The Effect of Transcranial Direct Current Stimulation on Relapse, Anxiety, and Depression in Patients With Opioid Dependence Under Methadone Maintenance Treatment: A Pilot Study

机译:经颅直流刺激对阿甲酸酮维持治疗依赖性患者复发,焦虑和抑郁症的影响:试验研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background and Patients under methadone maintenance therapy (MMT) are susceptible to several complications including mental disturbances and risk of relapse. The present study was designed to evaluate the effects of tDCS on relapse, depression, and anxiety of opioid-dependent patients under methadone maintenance treatment (MMT). Methods: It was a randomized-clinical trial that conducted among 27 male patients referred to the outpatient addiction clinic of Ibn-e-Sina psychiatric hospital in Mashhad from July 2018 to May 2019. Participants were allocated to two treatment groups including intervention and sham groups. The intervention group received seven sessions of tDCS, in the F3 (cathode) and F4 (anode) areas of the brain, each one lasts 20 min, in two consecutive weeks. Depression, anxiety, and stress scale-21 (DASS-21) were measured before, during, and after the intervention in patients under MMT. Relapse on the morphine, cannabis, and methamphetamine was screened by urine dipstick tests of morphine, cannabis, and methamphetamine. Results: Depression, anxiety, and stress of participants were significantly reduced in the intervention group compared with the control after the seventh session of tDCS (P < 0.001, P=0.01, and P=0.01, respectively). In addition, the relapse rate showed no significant changes between the two groups (P=0.33). Conclusion: Overall, our study demonstrated that depression, anxiety, and stress of participants were significantly reduced after the seventh session of tDCS, but did not affect on the relapse rate. Therefore, it can be applied as a safe and effective technique to relieve mental disorder among receiving MMT.
机译:在美沙酮维持治疗(MMT)下的背景和患者易于几种并发症,包括心理障碍和复发风险。本研究旨在评估TDCS对阿甲酸酮维持治疗(MMT)下阿片类药物依赖性患者复发,抑郁和焦虑的影响。方法:是2018年7月至2019年5月,27名男性患者在Mashhad的27名男性患者中进行的随机临床试验,该临床试验在Mashhad于2019年5月至5月。参加者分配给两个治疗组,包括干预和假组。干预组在大脑的F3(阴极)和F4(阳极),每一个连续两周内持续20分钟。在MMT下患者的干预之前,期间和之后测量抑郁症,焦虑和压力标度-21(DASS-21)。通过吗啡,大麻和甲基苯丙胺的尿液Dipstick测试筛选吗啡,大麻和甲基苯丙胺的复发。结果:抑郁症,焦虑和应激在干预组中显着降低,与TDCS第七次(P <0.001,P = 0.01和P = 0.01)进行控制比较。此外,复发率显示两组之间没有显着变化(P = 0.33)。结论:总体而言,我们的研究表明,在TDC的第七届会议后,参与者的抑郁症,焦虑和应力显着降低,但不影响复发率。因此,它可以作为一种安全有效的技术来缓解接收MMT之间的精神障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号